Innovotech, Inc. (IOT.V)
0.09
+0.01
(+12.50%)
CAD |
TSXV |
Nov 13, 16:00
Innovotech Enterprise Value : 5.180M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 5.180M |
| November 12, 2026 | 4.635M |
| November 11, 2026 | 4.363M |
| November 10, 2026 | 3.546M |
| November 09, 2026 | 3.546M |
| November 06, 2026 | 3.546M |
| November 05, 2026 | 3.546M |
| November 04, 2026 | 3.819M |
| November 03, 2026 | 4.091M |
| November 02, 2026 | 4.091M |
| October 30, 2026 | 3.819M |
| October 29, 2026 | 3.819M |
| October 28, 2026 | 3.819M |
| October 27, 2026 | 3.819M |
| October 26, 2026 | 3.819M |
| October 23, 2026 | 3.819M |
| October 22, 2026 | 3.819M |
| October 21, 2026 | 3.819M |
| October 20, 2026 | 3.819M |
| October 19, 2026 | 3.819M |
| October 16, 2026 | 3.819M |
| October 15, 2026 | 3.819M |
| October 14, 2026 | 3.819M |
| October 13, 2026 | 3.819M |
| October 09, 2026 | 3.819M |
| Date | Value |
|---|---|
| October 08, 2026 | 3.819M |
| October 07, 2026 | 3.819M |
| October 06, 2026 | 3.819M |
| October 05, 2026 | 3.819M |
| October 02, 2026 | 3.819M |
| October 01, 2026 | 3.819M |
| September 30, 2026 | 4.091M |
| September 29, 2026 | 3.647M |
| September 28, 2026 | 3.647M |
| September 25, 2026 | 3.647M |
| September 24, 2026 | 3.647M |
| September 23, 2026 | 4.192M |
| September 22, 2026 | 4.192M |
| September 21, 2026 | 4.192M |
| September 18, 2026 | 4.192M |
| September 17, 2026 | 4.192M |
| September 16, 2026 | 4.192M |
| September 15, 2026 | 4.192M |
| September 14, 2026 | 3.919M |
| September 11, 2026 | 3.647M |
| September 10, 2026 | 3.647M |
| September 09, 2026 | 3.647M |
| September 08, 2026 | 3.647M |
| September 04, 2026 | 3.919M |
| September 03, 2026 | 3.919M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Arch Biopartners, Inc. | 65.90M |
| Kane Biotech, Inc. | 7.260M |
| Quest PharmaTech, Inc. | -- |
| BriaCell Therapeutics Corp. | 12.59M |
| Vaxil Bio Ltd. | -0.0258M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.3903M |
| Revenue (Quarterly) | 0.6618M |
| Total Expenses (Quarterly) | 1.050M |
| EPS Diluted (Quarterly) | -0.0071 |
| Gross Profit Margin (Quarterly) | 29.78% |
| Profit Margin (Quarterly) | -58.98% |
| Earnings Yield | -25.78% |
| Normalized Earnings Yield | -26.78 |